London Equities Gain as Investors Rejoice Earnings & Vaccine Optimism

4 min read | February 16, 2021 11:07 AM GMT | By Team Kalkine Media

UK stock markets extended the gains on Tuesday, 16 February tracking the buoyant sentiments amidst the global equity investors with Japan’s Nikkei 225 hovering past its 30-year high. The renewed optimism around the upcoming corporate earnings in the week and the ongoing inoculation drive has seemingly rejoiced the market participants with an expectation of catalytic economic recovery.

London equities shine

The headline FTSE 100 pared gains partially in the mid-morning deals on Tuesday but was still trading in positive territory at 6,765.65, at around 1029 GMT, up 0.14 per cent, from the previous close of 6,756.11. In the intraday session so far, the index has shuttled between a high and low of 6,799.92 and 6,756.11, respectively.

Apart from today’s surge, the benchmark FTSE 100 has already amassed a gain of 5.44 per cent in February so far even with a 1 per cent GDP growth in Q4 FY20 and the Bank of England resisting to introduce a negative interest rate regime in its policy meeting in the first week of this month. Other broader stock indices have fared in a much similar manner with the FTSE 250, FTSE 350 and FTSE All-Share rising between 5.50 and 6.20 per cent.

GBP extends strength

Following the equities, the pound sterling has also gained strength in the present month against the greenback. The Great Britain pound (GBP) has staged a gain of more than 200 basis points against the United States dollar (USD) in February so far rising to a level above 1.39. At around 1036 GMT on Tuesday, the GBP vs USD pair was trading at 1.3924, up 0.15 per cent, from the previous close of 1.3903.

During the day so far, the currency pair has hovered between a range of 1.3902 and 1.3952, at the interbank foreign exchange market. The Bank of England had fixed a reference exchange rate of 1.3912 USD and 1.1467 EUR against a unit of pound sterling on 15 February.

Macro data and earnings steer markets

The Office for National Statistics is set to announce the CPI-based inflation figures for the month of January on 17 February, while the GFK consumer confidence is slated to be declared on 19 February. The dissemination of macroeconomic data weeks before the Budget presentation is likely to assist the London equities along with the guidance provided by the heavyweight companies.

Rio Tinto, British American Tobacco, Barclays, Smith & Nephew, Natwest Group and Segro are some of the major corporations that are scheduled to announce their Q4 and FY20 results in the present week. The extant pace of the vaccination programme has been quite eventful in restoring the lost confidence of the investors.

Vaccine optimism

In more than a three-month long jab distribution and immunisation, the healthcare authorities have vaccinated over 15 million people with the first dose across various jurisdictions in the United Kingdom, translating into a cumulative proportion of over 25 per cent of all the adults. The government is now focusing on vaccinating all the priority groups by May and all the adults by September this year as more vaccine shots are likely to be received in the second half of 2021.

Prime Minister Boris Johnson has recently said that the exact effectiveness of the vaccines in reducing the spread of infection can’t be ascertained as the authorities don’t have enough data. Irrespective of the large-scale vaccination programme, the rate of infection is still a worrying concern for the healthcare administration with around 1,600 people per day seeking hospital admissions.

The picture will be more clear in the forthcoming weeks as the UK is set to come out of the national lockdown restrictions. Reopening of businesses, and the rate of infection and the probable response of vaccines towards the mutated strain is likely to take a toll on domestic equities going forward.


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Limited, Company No. 12643132 (Kalkine Media, we or us) and is available for personal and non-commercial use only. Kalkine Media is an appointed representative of Kalkine Limited, who is authorized and regulated by the FCA (FRN: 579414). The non-personalised advice given by Kalkine Media through its Content does not in any way endorse or recommend individuals, investment products or services suitable for your personal financial situation. You should discuss your portfolios and the risk tolerance level appropriate for your personal financial situation, with a qualified financial planner and/or adviser. No liability is accepted by Kalkine Media or Kalkine Limited and/or any of its employees/officers, for any investment loss, or any other loss or detriment experienced by you for any investment decision, whether consequent to, or in any way related to this Content, the provision of which is a regulated activity. Kalkine Media does not intend to exclude any liability which is not permitted to be excluded under applicable law or regulation. Some of the Content on this website may be sponsored/non-sponsored, as applicable. However, on the date of publication of any such Content, none of the employees and/or associates of Kalkine Media hold positions in any of the stocks covered by Kalkine Media through its Content. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music/video that may be used in the Content are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music or video used in the Content unless stated otherwise. The images/music/video that may be used in the Content are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.


Sponsored Articles


Investing Ideas

Previous Next